Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

Corticosteroids might be efficacious for treating children with COVID-19

Staff Writer
Staff Writer 1 year ago
Updated 2021/06/17 at 1:50 AM
Share
SHARE

A treatment used to reduce immune system activity and bodily inflammation may also be efficacious for children infected with COVID-19, a new study suggests.

More than 600 children were studied as part of a new release in the New England Journal of Medicine.

Corticosteroids were studied for treating conditions developed known as multi-system inflammatory syndrome in children and pediatric inflammatory multi-system syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS).

Children generally develop PIMS-TS within a few weeks of infection with COVID-19.

“The new study, supported by the EU’s Horizon 2020 programme, investigated two initial treatments for this condition: a type of steroid called corticosteroids (such as methyl prednisolone) and antibody treatment (called immunoglobulin),” according to a press release of the results.

“The antibodies come from human blood, and have been shown to reduce inflammation in the body. The study also compared initial treatment with steroids together with immunoglobulin.”

The three treatments of focus, including corticosteroids, led to reduced inflammation, improving symptoms caused by infection.

“The study has been a real example of international collaboration and the willingness of paediatricians in many countries to share their data and experience to enable important questions as to optimal treatment to be answered,” the press release reads.

“Our finding, that treatments with immunoglobulin, steroids or a combination of both agents all result in more rapid resolution of inflammation (and have similar rates of progression to organ failure or recovery from critical illness), will be of great value to paediatricians worldwide in their treatment of children with this new disorder.”

Photo: iStockPhoto

You Might Also Like

Only less than 7 percent of U.S. adults have good cardiometabolic health

Study shows the likely outcomes of very preterm born children

Researchers find that stress accelerates immune aging

Study finds heavy drinkers are significantly more likely to smoke

Researchers suggest menthol cigarettes may raise the possibility of youth smoking and addiction

TAGGED: corticosteroids, COVID-19, epidemiology
Staff Writer June 16, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Human infants are more active during sleep stages than previously known
Next Article A report examines the controversial FDA approval of aducanumab for Alzheimer’s disease

Recommended

Health

Only less than 7 percent of U.S. adults have good cardiometabolic health

1 Min Read
Health

Study shows the likely outcomes of very preterm born children

1 Min Read
Health

Researchers find that stress accelerates immune aging

2 Min Read
Health

Study finds heavy drinkers are significantly more likely to smoke

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?